Regular health monitoring Baseline testing before starting: Complete blood count (CBC) Comprehensive metabolic panel (liver, kidney function) Fasting glucose and insulin IGF-1 levels Thyroid panel (TSH, T3, T4) Follow-up testing: Every 3-6 months while using peptides Immediately if concerning symptoms Compare to baseline What to monitor: Blood sugar regulation Liver and kidney function Thyroid function IGF-1 levels (shouldn't be excessively elevated) Lipid profile When to stop: Any concerning blood markers Persistent side effects Signs of organ stress Unusual symptoms Cycling and breaks For growth hormone peptides: CJC-1295 + Ipamorelin: Can use 3-6+ months continuously GHRP-6: Cycle 8-12 weeks, break 4-8 weeks Hexarelin: Cycle 4 weeks, break 4+ weeks (not recommended for most) For healing peptides: BPC-157: Can use continuously TB-500: Can use continuously or cycle 8-16 weeks on, 4-8 weeks off GHK-Cu: Can use continuously Why breaks matter: Prevent receptor desensitization Allow natural hormone production to recover Reduce long-term risk Reset tolerance See peptide cycle planning guide and can you cycle different peptides
During the first one to two weeks, the body may need time to recalibrate
4 weeks 28 syringes 1 shot per day
In preclinical research, GH and IGF-1 are themselves anabolic and regenerative factors, suggesting potential complementarity
Second, CJC-1295 is not even one thing: it exists as two pharmacologically distinct forms a long-acting version with DAC (a Drug Affinity Complex that binds it to blood albumin for days) and a short-acting version without DAC (often sold as mod GRF 1-29)
relevant to athletic longevity and post-injury recovery Ipamorelin dosage: what clinical protocols look like Because ipamorelin is available through compounding pharmacies not as a mass-market OTC product dosing protocols vary by clinical indication, patient physiology, and the prescribing clinician's approach
